Mannitol Market Size, Share, Opportunities, And Trends By Form (Powder, Granules), By Application (Food, Pharmaceuticals, Industrial, Others), And By Geography - Forecasts From 2024 To 2029

The mannitol market is expected to grow at a CAGR of 4.24% reaching a market size of US$692.055 million in 2029 from US$517.442 million in 2022.

Mannitol is a type of sugar polyol or sugar alcohol with low solubility and hygroscopicity and is used as both a sweetener and a drug. Mannitol is naturally found in tree bark, fresh mushrooms, brown algae, seaweed, and most fruits and vegetables. Increased prevalence of certain diseases, a more dynamic lifestyle, and growing populations in all regions are expected to have a positive effect on the market. This product is used as an excipient in the pharmaceutical industry to treat kidney, brain, and heart diseases as well as to formulate pharmaceutical products. Additionally, it is employed in tableting applications as a bulking agent.

The consumer's quality of life has greatly improved, owing mostly to increased personal income. As a result of rising health consciousness among consumers, the population's eating habits have shifted substantially. Furthermore, firms are investing a lot of time and resources in developing products composed of natural ingredients and specialized goods that improve health. As a result, rising demand for low-calorie natural sweeteners is propelling the growth of the global market for mannitol throughout the projected period. The growing diabetic population is also driving expansion since mannitol has little to no effect on the consumer's blood sugar level.

Increasing application of mannitol as an artificial sweetener

The main driver of the market expansion is the growing use of mannitol as a food additive and artificial sweetener. Mannitol causes a much smaller rise in blood sugar when compared to sucrose. Consequently, more products are being used in diabetic food. In addition, there has been a noticeable shift toward healthier food options as a result of the growing rates of obesity and diabetes, which is helping the market expand. In addition, the demand for the product has increased due to the increasing use of mannitol in butter, frozen fish, pre-cooked pasta, and baby formula. Furthermore, as dietary habits change and health consciousness rises, consumers' preferences for low- and zero-calorie foods are growing, which has increased the demand for artificial sweeteners.

Increasing demand in food & beverages industry

Mannitol is used as a sweetener in various confectionary goods, especially sugar-free products. Due to low solubility and high latent heat, mannitol is extensively used to produce mint candies and bubble gums. It has a very low hygroscopicity, meaning that it does not absorb water from the air until the humidity level reaches 98 percent, which makes it an excellent covering for hard candies, dried fruits, chocolate coatings, and chewing gums. Mannitol's excellent flavour and texture make it a preferred excipient for chewable tablets.

Mannitol has a lower glycemic index than sucrose and is a sweetener for diabetic patients. Therefore, an increasing number of cases of obesity, diabetes, and metabolic syndrome, along with improved consumer awareness, has resulted in a positive expansion of mannitol.

Increasing cases of chronic diseases

The market for mannitol is expected to be driven primarily by the rising prevalence of chronic diseases, which can lead to diabetes and other cardiovascular diseases. Furthermore, the growing number of diabetes patients and their willingness to adjust to various sugar-free product options will drive the market for mannitol. Furthermore, 422 million people worldwide, mostly in low- and middle-income nations, have diabetes, according to the World Health Organization, and the disease is directly responsible for 1.6 million deaths annually.

Compared to carbohydrates, which are frequently used in low-calorie foods, mannitol has fewer calories. Mannitol is a good option for diabetic diets because it can be digested without the need for insulin. The demand for low-sugar and low-calorie products is rising in tandem with the rise in the number of patients with diabetes. People's awareness of the health benefits of consuming low-calorie sugar is expected to increase demand for mannitol in the upcoming years, and the market is expected to grow during the forecast period.

High demand from the pharmaceutical industry

The market has grown as a result of the expanding uses of the product, which include diuretics, excipients in pharmaceutical tablets, and the treatment of heart and lung conditions as well as renal failure. Accordingly, the market has grown as a result of the increasing use of mannitol in chewing gum, mint-flavored candies, and chewable tablets due to its low hygroscopicity and cooling effect. A positive market outlook is also being fueled by other factors, such as growing product adoption in bakery and confectionery items, growing use as a bulking agent for tableting applications, continuing research and development (R&D) activities, and ongoing technological advancements.

Asia Pacific is witnessing exponential growth during the forecast period

Asia Pacific region is anticipated to hold a significant market share in mannitol. This region will witness high growth during the forecast period due to the rising health copiousness among consumers, increased urbanization, and rising disposable income. Mannitol is in high demand in rising markets such as China and India. This region's market is expanding due to changing eating habits and rising demand for low-calorie products and drinks. Mannitol does not affect blood sugar levels, making them an excellent choice for diabetic individuals. As a result, increased diabetes incidence in countries such as India and China is driving demand in this area

Market key launches

• In November 2022, Roquette, a major pharmaceutical and nutraceutical excipients manufacturer, introduced two next-generation mannitol solutions for direct compression: Pearlitol CR-H and Pearlitol 200 GT. Both excipients were created specifically to address unique drug formulation issues in the pharmaceutical industry, assisting manufacturers in optimizing direct compression techniques and expanding into innovative application areas such as controlled-release tablets and tiny tabs.

Mannitol Market Scope:

 

Report Metric	Details
Market Size Value in 2022	US$517.442 million
Market Size Value in 2029	US$692.055 million
Growth Rate	CAGR of 4.24% from 2022 to 2029
Study Period:	2019 to 2029
Historical Data:	2019 to 2022
Base Year	2023
Forecast Period	2024 – 2029
Forecast Unit (Value)	USD Million
Segments Covered	Form Application Geography
Companies Covered	Roquette Freres Company Cargill, Incorporated. Ingredion Incorporated SPI Pharm Singsino Group Ltd.
Regions Covered	North America, South America, Europe, Middle East and Africa, Asia Pacific
Customization Scope	Free report customization with purchase

 

Segmentation:

• By Form
  • Powder
  • Granules
• By Application
  • Food
  • Pharmaceuticals
  • Industrial
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Others

---

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. Analyst View

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Analyst View

5. MANNITOL MARKET, BY FORM

5.1. Introduction

5.2. Powder

5.2.1. Market Trends and Opportunities

5.2.2. Growth Prospects

5.2.3. Geographic Lucrativeness

5.3. Granules

5.3.1. Market Trends and Opportunities

5.3.2. Growth Prospects

5.3.3. Geographic Lucrativeness

6. MANNITOL MARKET, BY APPLICATION

6.1. Introduction

6.2. Food

6.2.1. Market Trends and Opportunities

6.2.2. Growth Prospects

6.2.3. Geographic Lucrativeness

6.3. Pharmaceuticals

6.3.1. Market Trends and Opportunities

6.3.2. Growth Prospects

6.3.3. Geographic Lucrativeness

6.4. Industrial

6.4.1. Market Trends and Opportunities

6.4.2. Growth Prospects

6.4.3. Geographic Lucrativeness

6.5. Others

6.5.1. Market Trends and Opportunities

6.5.2. Growth Prospects

6.5.3. Geographic Lucrativeness

7. MANNITOL MARKET, BY GEOGRAPHY

7.1. Introduction

7.2. North America

7.2.1. By Form

7.2.2. By Application

7.2.3. By Country

7.2.3.1. United States

7.2.3.1.1. Market Trends and Opportunities

7.2.3.1.2. Growth Prospects

7.2.3.2. Canada

7.2.3.2.1. Market Trends and Opportunities

7.2.3.2.2. Growth Prospects

7.2.3.3. Mexico

7.2.3.3.1. Market Trends and Opportunities

7.2.3.3.2. Growth Prospects

7.3. South America

7.3.1. By Form

7.3.2. By Application

7.3.3. By Country

7.3.3.1. Brazil

7.3.3.1.1. Market Trends and Opportunities

7.3.3.1.2. Growth Prospects

7.3.3.2. Argentina

7.3.3.2.1. Market Trends and Opportunities

7.3.3.2.2. Growth Prospects

7.3.3.3. Others

7.3.3.3.1. Market Trends and Opportunities

7.3.3.3.2. Growth Prospects

7.4. Europe

7.4.1. By Form

7.4.2. By Application

7.4.3. By Country

7.4.3.1. United Kingdom

7.4.3.1.1. Market Trends and Opportunities

7.4.3.1.2. Growth Prospects

7.4.3.2. Germany

7.4.3.2.1. Market Trends and Opportunities

7.4.3.2.2. Growth Prospects

7.4.3.3. France

7.4.3.3.1. Market Trends and Opportunities

7.4.3.3.2. Growth Prospects

7.4.3.4. Spain

7.4.3.4.1. Market Trends and Opportunities

7.4.3.4.2. Growth Prospects

7.4.3.5. Others

7.4.3.5.1. Market Trends and Opportunities

7.4.3.5.2. Growth Prospects

7.5. Middle East and Africa

7.5.1. By Form

7.5.2. By Application

7.5.3. By Country

7.5.3.1. Saudi Arabia

7.5.3.1.1. Market Trends and Opportunities

7.5.3.1.2. Growth Prospects

7.5.3.2. UAE

7.5.3.2.1. Market Trends and Opportunities

7.5.3.2.2. Growth Prospects

7.5.3.3. Israel

7.5.3.3.1. Market Trends and Opportunities

7.5.3.3.2. Growth Prospects

7.5.3.4. Others

7.5.3.4.1. Market Trends and Opportunities

7.5.3.4.2. Growth Prospects

7.6. Asia Pacific

7.6.1. By Form

7.6.2. By Application

7.6.3. By Country

7.6.3.1. Japan

7.6.3.1.1. Market Trends and Opportunities

7.6.3.1.2. Growth Prospects

7.6.3.2. China

7.6.3.2.1. Market Trends and Opportunities

7.6.3.2.2. Growth Prospects

7.6.3.3. India

7.6.3.3.1. Market Trends and Opportunities

7.6.3.3.2. Growth Prospects

7.6.3.4. South Korea

7.6.3.4.1. Market Trends and Opportunities

7.6.3.4.2. Growth Prospects

7.6.3.5. Indonesia

7.6.3.5.1. Market Trends and Opportunities

7.6.3.5.2. Growth Prospects

7.6.3.6. Thailand

7.6.3.6.1. Market Trends and Opportunities

7.6.3.6.2. Growth Prospects

7.6.3.7. Others

7.6.3.7.1. Market Trends and Opportunities

7.6.3.7.2. Growth Prospects

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

8.1. Major Players and Strategy Analysis

8.2. Market Share Analysis

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Competitive Dashboard

9. COMPANY PROFILES

9.1. Roquette Freres Company

9.2. Cargill, Incorporated.

9.3. Ingredion Incorporated

9.4. SPI Pharm

9.5. Singsino Group Ltd.,

9.6. Merck Millipore Corporation

9.7. Bright Moon Seaweed

Roquette Freres Company

Cargill, Incorporated.

Ingredion Incorporated

SPI Pharm

Singsino Group Ltd.,

Merck Millipore Corporation

Bright Moon Seaweed